BioCatalystWatch
PHARWorkspace / PHAR / OverviewCompany library
Price
Market cap
Next catalystNov 2026Joenja® (leniolisib) — CVID Phase 2 · Phase 2 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

Joenja® (leniolisib)

PI3Kδ

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Joenja® (leniolisib)

PI3Kδ

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Other pipelines

α-galactosidase

PreINDP1P2P3FilingApproved
α-glucosidase

PreINDP1P2P3FilingApproved
Napazimone (KL1333)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Joenja® (leniolisib)

PI3Kδ

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Partner / License out

PreINDP1P2P3FilingApproved

Approved / commercial

Kallikrein

Approved

PreINDP1P2P3FilingApproved
Joenja® (leniolisib)

PI3Kδ

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

History / paused

PreINDP1P2P3FilingApproved

Financial position

Cash and cash equivalents

Source and basis

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

PHAR PR & News

PHAR SEC archive